Company News
-
October 14, 2025
bioMérieux invests in Allergen Alert, a startup resulting from its intrapreneurship program
bioMérieux has just acquired a stake in Allergen Alert, an innovative startup specializing in the rapid detection of food allergens for individuals and professionals. -
September 29, 2025
bioMérieux publishes a Bioethics Charter: A first in the diagnostics sector
bioMérieux confirms its ethical commitment to clinical research through a Bioethics Charter that guarantees transparency, accountability, and respect for human dignity. In particular, it aims to protect research participants when collecting and using biological samples and personal data. -
July 23, 2025
bioMérieux and Moderna Collaborate to Advance individualized Cancer Therapies
bioMérieux has a long history of collaboration with Moderna, a biotechnology company that gained worldwide recognition during the COVID-19 pandemic for its rapid development of a mRNA-based vaccine. Today, this partnership is helping accelerate the development of individualized cancer treatments. -
April 17, 2025
bioMérieux Embarks its Customers in a Circular Economy Initiative
BIOLOOP™ is an innovative project to recycle plastic Petri dishes from infectious waste into new reagents packaging—reducing CO₂ emissions and supporting a circular economy in healthcare. -
April 10, 2025
bioMérieux partners with Mila to harness artificial intelligence for diagnostics
This partnership aims to develop innovative solutions to improve the accuracy and efficiency of in vitro diagnostic tools and detection of antibiotic resistance.